FDA approves Moderna mRNA flu vaccine
4 outlets covered the same story. Here's how their headlines landed on the −5 (Far Left) to +5 (Far Right) spectrum — a 0.0-point gap between the most-left and most-right framing.
How the coverage framed it
Coverage of the FDA's approval of Moderna's mRNA flu vaccine was remarkably uniform across all four outlets, with a bias spread of exactly 0.0 points. Every headline led with a straightforward, factual construction centered on the word "approves," with no outlet employing charged language, skeptical framing, or advocacy-driven phrasing. The only notable stylistic variation came from the Wall Street Journal, whose headline extended beyond the core approval fact to note it was "a Win for Moderna After Arduous Review" — a characterization that, while still factual rather than ideological, added modest business-narrative context absent from the other outlets. CNN and Boston Globe produced lean, wire-style headlines, while the New York Times followed its standard institutional formatting. None of the signals flagged any ideological lean, making this a rare example of near-identical framing across outlets with otherwise differing editorial identities.
- +0.0CNN · CenterFDA approves first mRNA-based flu vaccine
- ▸ neutral 'approves', plain factual wire framing
- ▸ no loaded language or ideological signal
- +0.0NY Times · CenterF.D.A. Approves Moderna’s mRNA Flu Vaccine
- ▸ neutral 'approves', plain factual wire framing
- ▸ no ideological signal
- +0.0Wall Street Journal · CenterFDA Approves First mRNA Flu Vaccine in Win for Moderna After Arduous Review
- ▸ neutral 'approves', 'win for Moderna' is factual characterization
- ▸ no ideological signal
- +0.0Boston Globe · CenterFDA approves Moderna’s mRNA flu vaccine
- ▸ plain factual wire-style headline
- ▸ no loaded language
Scores are AI estimates of headline language, not factual ratings. Each headline is scored 0 (neutral) outward to Far Left / Far Right by Claude and Grok.